$5.05
-0.03-0.59%
At Close: -
$5.10
0.050.99%
After Hours: 3:00 PM EDT
15 minutes delayed
T2 Biosystems
TTOONASDAQ
T2 Biosystems (NASDAQ:TTOO) Stock, Analyst Ratings, Price Targets, Predictions
T2 Biosystems Inc has a consensus price target of $1.02, established from looking at the 7 latest analyst ratings. The last 3 analyst ratings were released from Canaccord Genuity, Alliance Global Partners, and Alliance Global Partners on April 29, 2024, July 13, 2023, and January 24, 2023. With an average price target of $1.52 between Canaccord Genuity, Alliance Global Partners, and Alliance Global Partners, there's an implied -70.13% downside for T2 Biosystems Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
Alliance Global Partners
BTIG
1calculated from analyst ratings
Analyst Ratings for T2 Biosystems
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/29/2024 | Buy Now | -41.18% | Canaccord Genuity | Kyle Mikson | $12 → $3 | Maintains | Hold | Get Alert |
| 07/13/2023 | Buy Now | -98.63% | Alliance Global Partners | Ben Haynor | $12 → $7 | Maintains | Neutral | Get Alert |
| 01/24/2023 | Buy Now | -70.59% | Alliance Global Partners | Ben Haynor | $220 → $150 | Maintains | Neutral | Get Alert |
| 10/14/2022 | Buy Now | -50.98% | Canaccord Genuity | Kyle Mikson | $1250 → $250 | Downgrade | Buy → Hold | Get Alert |
| 07/07/2022 | Buy Now | — | Alliance Global Partners | Ben Haynor | — | Downgrade | Buy → Neutral | Get Alert |
| 07/07/2022 | Buy Now | — | BTIG | Mark Massaro | — | Downgrade | Buy → Neutral | Get Alert |
| 02/18/2022 | Buy Now | -86.27% | Alliance Global Partners | Ben Haynor | → $3500 | Upgrade | Neutral → Buy | Get Alert |
FAQ
What is the target price for T2 Biosystems (TTOO) stock?
The latest price target for T2 Biosystems (NASDAQ:TTOO) was reported by Canaccord Genuity on April 29, 2024. The analyst firm set a price target for $3.00 expecting TTOO to fall to within 12 months (a possible -41.18% downside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for T2 Biosystems (TTOO)?
The latest analyst rating for T2 Biosystems (NASDAQ:TTOO) was provided by Canaccord Genuity, and T2 Biosystems maintained their hold rating.
When was the last upgrade for T2 Biosystems (TTOO)?
The last upgrade for T2 Biosystems Inc happened on February 18, 2022 when Alliance Global Partners raised their price target to $0.7. Alliance Global Partners previously had a neutral for T2 Biosystems Inc.
When was the last downgrade for T2 Biosystems (TTOO)?
The last downgrade for T2 Biosystems Inc happened on October 14, 2022 when Canaccord Genuity changed their price target from $12.5 to $2.5 for T2 Biosystems Inc.
When is the next analyst rating going to be posted or updated for T2 Biosystems (TTOO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of T2 Biosystems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for T2 Biosystems was filed on April 29, 2024 so you should expect the next rating to be made available sometime around April 29, 2025.
Is the Analyst Rating T2 Biosystems (TTOO) correct?
While ratings are subjective and will change, the latest T2 Biosystems (TTOO) rating was a maintained with a price target of $12.00 to $3.00. The current price T2 Biosystems (TTOO) is trading at is $5.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.